GH1 and hyperinsulinism: The impairment of GH secretion in obese would reflect alterations in the neuroendocrine control of the somatotropic axis and/or metabolic alterations such as hyperinsulinism and elevation of circulating free fatty acids [36]; reduction of GH half life in obese subjects has also been demonstrated [37,38].